UK Shuffle Will Undermine Stem Cell Progress
This article was originally published in SRA
Executive Summary
At first glance the new UK coalition government's plans to cut bureaucracy in the healthcare sector, including streamlining the functions of certain regulatory bodies, sound like an answer to the prayers of the regulated industry and patients alike. But they should tread with caution: this may merely be a post-election quick fix that could lead to a setback in critical areas such as global stem cell research.